All In MedTech

PMA device

VenaSeal Closure System

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

6

PMA pathway

Device trials

4

Naming "VenaSeal"

MAUDE reports

191

Brand "VenaSeal", since 2015

PubMed studies

77

Mentioning "VenaSeal"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing VenaSeal Closure System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 6 decisions filed under this name.

3 more FDA decisions with a free account

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "VenaSeal", any status and sponsor, newest update first.

Open in Trial Radar
  • Medtronic EndovascularPublic (MDT)

    NCT03820947 · 506 participants · Start Feb 5, 2020 · Primary completion Jun 12, 2024

    Device: VenaSeal™ System; Endothermal Ablation (ETA) · For: Venous Reflux

    Sites: Prescott Valley, Arizona; Tucson, Arizona; Fresno, California · 32 sites in all

  • Medtronic EndovascularPublic (MDT)

    NCT03455699 · 114 participants · Start Jul 2016 · Primary completion Jan 2019

    Device: VenaSeal SCS; ClosureFast Radiofrequency Ablation (RFA) and 1 more · For: Great Saphenous Vein (GSV) With Venous Reflux Disease

    Sites: Scottsdale, Arizona; San Diego, California; Greenwood Village, Colorado · 9 sites in all

  • Medtronic EndovascularPublic (MDT)

    NCT01807585 · 242 participants · Start Mar 2013 · Primary completion Dec 2013

    Device: VenaSeal SCS; ClosureFast Radiofrequency Ablation (RFA) and 1 more · For: Great Saphenous Vein (GSV) With Venous Reflux Disease

    Sites: Scottsdale, Arizona; San Diego, California; Greenwood Village, Colorado · 10 sites in all

1 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "VenaSeal", and for the whole product code for context.

This brand

191 reports: 19 malfunction, 167 injury, 4 death

Whole product code PJQ

1,343 reports: 80 malfunction, 1,243 injury, 19 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "VenaSeal"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.